Contact: Westwicke PartnersJamar IsmailPhone: 415-513-1282Email: email@example.comTJ JohnsonPresident / CEOHTG Molecular DiagnosticsPhone: 520-547-2827 x130Email: firstname.lastname@example.org
TUCSON, Ariz., Nov. 03, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that the Company will release 2016 third quarter financial results after market close on Monday, November 14, 2016. Company management will host an investment-community conference call beginning at 4:30pm Eastern Time on Monday, November 14 to discuss these results and answer questions. Individuals interested in listening to the conference call may do so by dialing (866) 394-4225 for domestic callers, or (678) 509-7535 for international callers (conference ID: 9555990), or from the webcast on the "Investors" section of the Company's website at: http://www.htgmolecular.com. The webcast will be available on the Company's website for 90 days following the completion of the call. About HTG: Headquartered in Tucson, Arizona, HTG's mission is to empower precision medicine at the local level. In 2013 the company commercialized its HTG Edge instrument platform and a portfolio of RNA assays that leverage HTG's proprietary nuclease protection chemistry. HTG's product offerings have since expanded to include its HTG EdgeSeq product line, which automates sample and targeted library preparation for next-generation sequencing. Additional information is available at www.htgmolecular.com.